The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real world evidence comparison of first-line (1L) immune-oncology(IO)/tyrosine kinase inhibitor (TKI) vs. IO/IO combination therapy in renal cell carcinoma (RCC).
 
Patrick Bolan
Employment - C2i Genomics
Consulting or Advisory Role - C2i Genomics
 
Gavin Hui
No Relationships to Disclose
 
Yen Low
Employment - Atropos
Stock and Other Ownership Interests - Atropos
 
Saurabh Gombar
Employment - Atropos
Leadership - Atropos
Stock and Other Ownership Interests - Atropos
 
Alice C. Fan
Employment - BeiGene (I); Silverado Hospice (I)
Stock and Other Ownership Interests - Antelope Valley Care Center (I); Molecular Decisions
Consulting or Advisory Role - verily
Research Funding - Calithera Biosciences (Inst); Earli (Inst); Filtricine (Inst); MagARRAY (Inst); The Cancer League (Inst)
Patents, Royalties, Other Intellectual Property - Stanford Patent has been licensed (Inst)
 
Divya Ahuja Parikh
No Relationships to Disclose
 
Sumit Shah
Honoraria - Janssen
Consulting or Advisory Role - Grand Rounds/Included Health; Natera
Research Funding - Genentech
 
Sandy Srinivas
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Janssen Oncology; Merck; Novartis; Seagen
Research Funding - AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Exelixis (Inst); Genentech (Inst); Merck (Inst); Seattle Genetics/Astellas (Inst)
Other Relationship - Pfizer
 
Ali Raza Khaki
Honoraria - HMP; OncLive/MJH Life Sciences
Consulting or Advisory Role - Gilead Sciences (Inst)
Research Funding - 23andMe (Inst); Janssen Oncology (Inst)
Other Relationship - Tempus
(OPTIONAL) Uncompensated Relationships - Janssen; Seattle Genetics/Astellas